Jesse J. Geiger - 17 Mar 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Mar 2026, 16:45:41 UTC
Prior SEC filing
07 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger

Key filing fact

Jesse J. Geiger filed Form 4 for Medpace Holdings, Inc. (MEDP) on 19 Mar 2026.

Key facts

  • This page summarizes Jesse J. Geiger's Form 4 filing for Medpace Holdings, Inc. (MEDP).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Mar 2026, 16:45.

Change

  • Previous filing in this sequence was filed on 07 Nov 2025.
  • Current net transaction value: -$14,436,197.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001677399 Primary reporting owner

GEIGER JESSE J

Relationship
President
Address
C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger
Signature date
19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Options Exercise

Transaction value
Shares
+31,707
Change %
+211%
Price
$138.87*
Shares after
46,707
Date
17 Mar 2026
Ownership
Direct
MEDP transaction

Common Stock

Sale

Transaction value
$14,436,197
Shares
-31,707
Change %
-68%
Price
$455.30
Shares after
15,000
Date
17 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEDP transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-31,707
Change %
-100%
Price
$0.000000*
Shares after
0
Date
17 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,707
Exercise price
$138.87
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Footnote F2

The option vested in full on February 15, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .